Sandoz receives regulatory approval from NMPA for Rosuvastatin
Sandoz has announced that it has received regulatory approval from Chinas National Medical Products Administration (NMPA) for its generic Rosuvastatin, under the NMPAs Quality Consistency Evaluation (QCE) system
Click one of our representatives below to chat on WhatsApp ,no call facility whatsaap this numbers only Chat .
Sales manager Supporter Manger
How can i help you?Sales manager Supporter MangerI am online